| Actos EU/1/00/150/011 |
Pioglitazone |
Takeda Pharma A/S |
— |
| ADCETRIS 50 mg powder for concentrate for solution for infusion EU/1/12/794/001 |
Brentuximab vedotin |
Takeda Pharma A/S |
— |
| Advate 1000 IU/2 ml powder and solvent for solution for injection EU/1/03/271/009 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 1000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/003 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 1500 IU/5 ml powder and solvent for solution for injection EU/1/03/271/004 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 2000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/005 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 250 IU/2 ml powder and solvent for solution for injection EU/1/03/271/007 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 250 IU/5 ml powder and solvent for solution for injection EU/1/03/271/001 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 3000 IU/5 ml powder and solvent for solution for injection EU/1/03/271/006 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 500 IU/2 ml powder and solvent for solution for injection EU/1/03/271/008 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| Advate 500 IU/5 ml powder and solvent for solution for injection EU/1/03/271/002 |
Recombinant coagulation fviii (octocog alfa) |
Takeda Manufacturing Austria AG |
— |
| ADZYNMA 1500 IU powder and solvent for solution for injection EU/1/24/1837/002 |
Apadamtase alfa |
Takeda Manufacturing Austria AG |
— |
| ADZYNMA 500 IU powder and solvent for solution for injection EU/1/24/1837/001 |
Apadamtase alfa |
Takeda Manufacturing Austria AG |
— |
| Alunbrig 180 mg film-coated tablets EU/1/18/1264/009-010 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 30 mg film-coated tablets EU/1/18/1264/001-004 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 90 mg film-coated tablets EU/1/18/1264/005-008 |
Brigatinib |
Takeda Pharma A/S |
— |
| Cinryze 500 IU powder and solvent for solution for injection EU/1/11/688/001 |
C1 inhibitor |
Takeda Manufacturing Austria AG |
— |
| CONTROLOC Control 20 mg Gastro-resistant tablet EU/1/09/515/001-004 |
Pantoprazole sodium sesquihydrate |
Takeda GmbH |
— |
| Dengue Tetravalent Vaccine (Live, Attenuated) Takeda EU/1/22/1699/001 |
Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) |
Takeda GmbH |
— |
| Dengue Tetravalent Vaccine (Live, Attenuated) Takeda EU/1/22/1699/002 |
Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) |
Takeda GmbH |
— |
| Dengue Tetravalent Vaccine (Live, Attenuated) Takeda EU/1/22/1699/003 |
Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) |
Takeda GmbH |
— |
| Dengue Tetravalent Vaccine (Live, Attenuated) Takeda EU/1/22/1699/004 |
Dengue virus serotype 1# (live, attenuated), Dengue virus, serotype 2, live, attenuated, Dengue virus serotype 3# (live, attenuated), Dengue virus serotype 4# (live, attenuated) |
Takeda GmbH |
— |
| Deqsiga 100 mg/mL solution for infusion/human normal immunoglobulin (IVIg) EU/1/25/1919/001-002 |
Human Normal Immunoglobulin (IV) |
Takeda Manufacturing Austria AG |
— |
| Edarbi 20 mg tablets EU/1/11/734/001-004 |
Azilsartan medoxomil |
Takeda Pharma A/S |
— |
| Edarbi 40 mg tablets EU/1/11/734/005-008 |
Azilsartan medoxomil |
Takeda Pharma A/S |
— |
| Edarbi 80 mg tablets EU/1/11/734/009-011 |
Azilsartan medoxomil |
Takeda Pharma A/S |
— |
| Elaprase 2 mg/ml concentrate for solution for infusion EU/1/06/365/1-3 |
Idursulfase |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Entyvio 108 mg solution for injection in pre-filled pen EU/1/14/923/005-007 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 108 mg solution for injection in pre-filled syringe EU/1/14/923/002-004 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 300 mg powder for concentrate for solution for infusion EU/1/14/923/001 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Equasym XL 10 mg modified-release capsules, hard PA23211/001/001 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Equasym XL 20 mg modified-release capsules, hard PA23211/001/002 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Equasym XL 30 mg modified-release capsules, hard PA23211/001/003 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Equasym XL 40 mg modified-release capsules, hard PA23211/001/004 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Equasym XL 50 mg modified-release capsules, hard PA23211/001/005 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Equasym XL 60 mg modified-release capsules, hard PA23211/001/006 |
Methylphenidate hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Firazyr 30 mg solution for injection in pre-filled syringe EU/1/08/461/001-002 |
Icatibant |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Foznol 1000 mg Chewable Tablets PA23211/002/004 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 1000 mg Oral Powder PA23211/002/006 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 250 mg Chewable Tablets PA23211/002/001 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 500 mg Chewable Tablets PA23211/002/002 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Chewable Tablets PA23211/002/003 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Oral Powder PA23211/002/005 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Incresync 12.5 mg/30 mg film-coated tablets EU/1/13/842/01-09 |
Alogliptin (as benzoate), Pioglitazone (as hydrochloride) |
Takeda Pharma A/S |
— |
| Incresync 12.5 mg/45 mg film-coated tablets EU/1/13/842/010-018 |
Alogliptin (as benzoate), Pioglitazone (as hydrochloride) |
Takeda Pharma A/S |
— |
| Incresync 25 mg/30 mg film-coated tablets EU/1/13/842/019-027 |
Pioglitazone (as hydrochloride), Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Incresync 25 mg/45 mg film-coated tablets EU/1/13/842/028-036 |
Pioglitazone (as hydrochloride), Alogliptin (as benzoate) |
Takeda Pharma A/S |
— |
| Intuniv 1 mg prolonged-release tablets EU/1/15/1040/001-002 |
GUANFACINE HYDROCHLORIDE |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Intuniv 2 mg prolonged-release tablets EU/1/15/1040/003-005 |
GUANFACINE HYDROCHLORIDE |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Intuniv 3 mg prolonged-release tablets EU/1/15/1040/006-007 |
GUANFACINE HYDROCHLORIDE |
Takeda Pharmaceuticals International AG Ireland Branch |
— |